Literature DB >> 9063489

[Novel metastasis model of human lung cancer cells representing different histological types in SCID mice depleted of NK cells].

S Yano1, S Sone.   

Abstract

Metastasis is the major obstacle in cancer therapy. Lung cancer is divided into 4 histological groups, such as small cell carcinoma, squamous cell carcinoma, adenocarcinoma and large cell carcinoma, representing different clinical behaviors. Novel metastasis models of human lung cancer cells to the liver, kidneys and lymph nodes were established in SCID mice depleted of NK cells. In the model under study, small-cell carcinoma cells mainly formed lymph-node metastases, while squamous cell carcinoma cells mainly metastasized to the liver and kidneys. Moreover, adenocarcinoma cells formed lung metastases and malignant pleural effusion. These findings suggest that our model reflects clinical behavior of metastatic lung cancer and is useful for evaluation of antimetastatic modalities.

Entities:  

Mesh:

Year:  1997        PMID: 9063489

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  5 in total

1.  A novel animal model for bone metastasis in human lung cancer.

Authors:  Mi Li; Mingliang Zhou; Meng Gong; Junrong Ma; Fuxing Pei; Wesley G Beamer; Leonard D Shultz; Janet M Hock; Xijie Yu
Journal:  Oncol Lett       Date:  2012-02-01       Impact factor: 2.967

2.  Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.

Authors:  K Ichiki; N Mitani; Y Doki; H Hara; T Misaki; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer.

Authors:  T Yamaura; K Murakami; Y Doki; S Sugiyama; T Misaki; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

4.  Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway.

Authors:  Hirokazu Taniguchi; Tadaaki Yamada; Shinji Takeuchi; Sachiko Arai; Koji Fukuda; Shuichi Sakamoto; Manabu Kawada; Hiroyuki Yamaguchi; Hiroshi Mukae; Seiji Yano
Journal:  Cancer Sci       Date:  2017-06-08       Impact factor: 6.716

5.  TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.

Authors:  K Murakami; T Yamaura; K Suda; S Ohie; J Shibata; T Toko; Y Yamada; I Saiki
Journal:  Jpn J Cancer Res       Date:  1999-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.